Related Experiment Video

Updated: Jun 3, 2026

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

Risk of macrovascular complications in type 2 diabetes mellitus: endothelial microparticle profiles

Keun-Hwa Jung1, Kon Chu, Soon-Tae Lee

  • 1Department of Neurology, Clinical Research Institute, Seoul National University Hospital, Seoul, South Korea.

Cerebrovascular Diseases (Basel, Switzerland)
|March 18, 2011
PubMed
Abstract

Insights

Type 2 diabetes complications differ. Macrovascular issues are linked to dyslipidemia and higher endothelial microparticle (EMP) levels, suggesting EMPs may predict risk.

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Research
  • Diabetology

Background:

  • The impact of diabetes on small blood vessels (microangiopathy) is known, but risks to large vessels (macroangiopathy) are less understood.
  • Type 2 diabetes mellitus presents unique challenges in managing vascular complications.
  • Investigating differential risks and biomarkers for diabetic vascular disease is crucial.

Purpose of the Study:

  • To determine the differential risk factors for microangiopathy and macroangiopathy in type 2 diabetes.
  • To analyze the profile of endothelial microparticles (EMPs) in relation to these vascular complications.
  • To explore the potential of EMPs as biomarkers for diabetic vascular risk.

Main Methods:

  • Evaluated macroangiopathy (cerebrovascular, coronary, peripheral artery disease) and microangiopathy (retinopathy, nephropathy, neuropathy).
  • Compared clinical and laboratory factors in 149 patients with varying vascular complications.
  • Quantified EMPs using flow cytometry with specific antibodies (CD31, CD42b, AV, CD62E).

Main Results:

  • Longer diabetes duration, high HbA1c, and hypertension correlated with overall vascular complications.
  • Dyslipidemia and high BMI were linked to macroangiopathy; long duration and high HbA1c to microangiopathy.
  • Elevated EMP levels (CD31+/CD42b-, CD31+/AV+) were found in macroangiopathy patients and independently associated with macroangiopathy risk.

Conclusions:

  • Diabetic microangiopathy and macroangiopathy have distinct pathophysiological underpinnings.
  • Endothelial microparticle (EMP) measurement can aid in differentiating the risk of vascular complications in diabetes.
  • EMP analysis offers a promising avenue for personalized risk assessment in diabetic patients.

More Related Videos

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo10:39

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Published on: March 8, 2018

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...